Stem Cell Therapy Market Share, Opportunities, Industry 2031

Stem Cell Therapy Market Share, Opportunities, Industry 2031

Segments - Stem Cell Therapy Market by Therapeutic Area (Cardiovascular, Neurology, Oncology, and Orthopedic), Types (Autologous Stem Cell Therapy and Allogenic Stem Cell Therapy), End-users (Clinics and Hospitals), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4510 | 4.6 Rating | 71 Reviews | 166 Pages | Format : PDF Excel PPT

Report Description


The global stem cell therapy market size was valued at USD 8.8 billion in 2020 and is estimated to expand at a CAGR of 10.5% during the forecast period, 2021–2028. The growth of the market is attributed to consistent government funding and initiatives for regenerative medicine research and development activities in industrialized economies.

Stem Cell Therapy Market Key Takeaways

Stem cell therapy is a non-invasive procedure for repairing or replacing damaged or diseased tissues and cells. It is a type of regenerative medicine that employs the utilization of stem cells to cure a variety of ailments. These stem cells have the ability to self-replicate and heal other damaged cells and tissues in the body. Stem cell treatment received a lot of attention recently, due to increased occurrence of numerous chronic ailments and uncommon genetic diseases throughout the world. Induced pluripotent stem cells (iPSCs) are adult stem cells that have been genetically reprogrammed to mimic embryonic stem cells (ESCs). iPSCs are comparable to ESCs in that they can develop into specialized tissue cells based on gene expression, making them a viable alternative to ESCs. ESCs are involved with legislation and socio-ethical concerns relating to contraception, abortion, and in vitro fertilization, as it is derived from early-stage embryos. The use of iPSCs avoids the use of human embryos, eliminating social and ethical concerns.

The impact of the global spread of COVID-19 infection on the sector was minimal. Across various regions, several research institutes and government agencies were concentrating on speedy and effective technologies for the treatment of life-threatening illnesses, including COVID-19. In addition, various clinical trials in the field of regenerative medicine were undertaken. However, it is still in the early stages of research in comparison to the single umbilical cord stem cell market.

  • Increasing government initiatives for stem cell therapy in developed and developing countries is expected to drive market.
  • Rising awareness regarding accessibility of stem cell therapy is anticipated to propel the market.
  • Advancements in regenerative medicine in North America & Europe are projected to boost the market during the forecast period.
  • Ethical issues associated with stem cell therapy are expected to hinder the market growth in the coming years.
  • High-cost issues associated with stem cell therapy are anticipated to hamper the market growth during the forecast period.
  • Increasing investments in research, clinical trials, and emergence of iPSCs as an alternative to ESCs creates lucrative opportunities for the market players.

Scope of the Report

The report on the global stem cell therapy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Stem Cell Therapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Therapeutic Area (Cardiovascular, Neurology, Oncology, and Orthopedic), Types (Autologous Stem Cell Therapy and Allogenic Stem Cell Therapy), and End-users (Clinics and Hospitals)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

PHARMICELL Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; NuVasive, Inc.; Smith & Nephew; MEDIPOST Co., Ltd.; and Anterogen Co., Ltd.

Market Segment Insights

Oncology segment to expand at a considerable CAGR

On the basis of therapeutic area, the market is segmented into cardiovascular, neurology, oncology, and orthopedic. The oncology segment is projected to expand at a considerable CAGR during the forecast period due to increasing occurrence of cancer cases and effectiveness of stem cell therapy in treatment of cancer. The neurology segment is anticipated to account for a major market share during the forecast period, owing to the increasing prevalence of neurological disorders and high cost of therapy.

Stem Cell Therapy Market By Therapeutic Area

Allogenic Stem Cell Therapy segment to hold a significant share of the market

In terms of types, the market is divided into autologous stem cell therapy and allogenic stem cell therapy. The allogenic stem cell therapy segment is expected to hold a significant share of the market in the coming years, due to ease of production and manufacturing processes and the increasing availability of novel stem cell products. The autologous stem cell therapy segment accounts for a significant market share, as it provides high compatibility with human immune system, as the patients are their own donors of stem cells.

Hospitals segment to expand at a high rate during the forecast period

Based on end-users, the market is bifurcated into clinics and hospitals. The hospitals segment is expected to expand at a high rate during the forecast period, owing to the growing demand for stem cell treatments in hospitals to minimize difficulties caused by intrusive approaches such as surgical procedures. The clinics segment is expected to be grow rapidly during the forecast period, due to advancements in regenerative medicine.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period. Favorable government actions are responsible for significant regional growth. For example, the government of Canada and JDRF Canada announced a research grant of USD 6 million in November 2020 to speed up stem cell-based therapeutics for type 1 diabetes. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to growing prevalence of chronic diseases among people in the region.

Segments

The global market has been segmented on the basis of

Therapeutic Area
  • Cardiovascular
  • Neurology
  • Oncology
  • Orthopedic
Types
  • Autologous Stem Cell Therapy
  • Allogenic Stem Cell Therapy
End-users
  • Clinics
  • Hospitals
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players

Competitive Landscape

Key players competing in the global market are PHARMICELL Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; NuVasive, Inc.; Smith & Nephew; MEDIPOST Co., Ltd.; and Anterogen Co., Ltd.

The stem cell therapy market is extremely competitive, with a large number of big firms. Few big firms presently dominate the industry in terms of market share. Product breakthroughs and improvements in stem cell technologies by key market players are generating competition. Novadip Biosciences gained FDA clearance for its Investigational New Drug (IND) application for its autologous cell treatment product, NVD-003, in March 2021. Congenital Pseudarthrosis of the Tibia (CPT) is treated with this product. The company is expected to boost its market position by improving its product offerings and expanding its consumer base.

Stem Cell Therapy Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stem Cell Therapy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Stem Cell Therapy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Stem Cell Therapy Market - Supply Chain
  4.5. Global Stem Cell Therapy Market Forecast
     4.5.1. Stem Cell Therapy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Stem Cell Therapy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Stem Cell Therapy Market Absolute $ Opportunity
5. Global Stem Cell Therapy Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Stem Cell Therapy Market Size and Volume Forecast by Types
     5.3.1. Autologous Stem Cell Therapy
     5.3.2. Allogenic Stem Cell Therapy
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Stem Cell Therapy Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Stem Cell Therapy Market Size and Volume Forecast by End Users
     6.3.1. Clinics
     6.3.2. Hospitals
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Stem Cell Therapy Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Stem Cell Therapy Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Stem Cell Therapy Demand Share Forecast, 2019-2026
8. North America Stem Cell Therapy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Stem Cell Therapy Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Stem Cell Therapy Market Size and Volume Forecast by Types
     8.4.1. Autologous Stem Cell Therapy
     8.4.2. Allogenic Stem Cell Therapy
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Stem Cell Therapy Market Size and Volume Forecast by End Users
     8.7.1. Clinics
     8.7.2. Hospitals
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Stem Cell Therapy Demand Share Forecast, 2019-2026
9. Latin America Stem Cell Therapy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Stem Cell Therapy Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Stem Cell Therapy Market Size and Volume Forecast by Types
     9.4.1. Autologous Stem Cell Therapy
     9.4.2. Allogenic Stem Cell Therapy
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Stem Cell Therapy Market Size and Volume Forecast by End Users
     9.7.1. Clinics
     9.7.2. Hospitals
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Stem Cell Therapy Demand Share Forecast, 2019-2026
10. Europe Stem Cell Therapy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Stem Cell Therapy Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Stem Cell Therapy Market Size and Volume Forecast by Types
     10.4.1. Autologous Stem Cell Therapy
     10.4.2. Allogenic Stem Cell Therapy
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Stem Cell Therapy Market Size and Volume Forecast by End Users
     10.7.1. Clinics
     10.7.2. Hospitals
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Stem Cell Therapy Demand Share Forecast, 2019-2026
11. Asia Pacific Stem Cell Therapy Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Stem Cell Therapy Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Stem Cell Therapy Market Size and Volume Forecast by Types
     11.4.1. Autologous Stem Cell Therapy
     11.4.2. Allogenic Stem Cell Therapy
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Stem Cell Therapy Market Size and Volume Forecast by End Users
     11.7.1. Clinics
     11.7.2. Hospitals
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Stem Cell Therapy Demand Share Forecast, 2019-2026
12. Middle East & Africa Stem Cell Therapy Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Stem Cell Therapy Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Stem Cell Therapy Market Size and Volume Forecast by Types
     12.4.1. Autologous Stem Cell Therapy
     12.4.2. Allogenic Stem Cell Therapy
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Stem Cell Therapy Market Size and Volume Forecast by End Users
     12.7.1. Clinics
     12.7.2. Hospitals
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Stem Cell Therapy Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Stem Cell Therapy Market: Market Share Analysis
  13.2. Stem Cell Therapy Distributors and Customers
  13.3. Stem Cell Therapy Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. PHARMICELL Co., Ltd.
     13.4.2. JCR Pharmaceuticals Co., Ltd.
     13.4.3. NuVasive, Inc.
     13.4.4. Smith & Nephew
     13.4.5. MEDIPOST Co., Ltd.
     13.4.6. Anterogen Co., Ltd

Methodology

Our Clients

Nestle SA
Microsoft
General Mills
General Electric
sinopec
Siemens Healthcare
The John Holland Group
FedEx Logistics